MyCEI Login


Towards an HIV Cure: Understanding HIV Persistence and Therapeutic Approaches


Published Date: 11/06/2023

Expiration Date: 09/12/2026

CE Credit: CME:1


HIV cure has been limited to only a few cases over the past couple decades, starting with the Berlin Patient, but what is needed is a safer and scalable cure aimed at far broader populations of people living with HIV. This year, the International AIDS Society focused on HIV cure research from around the world at IAS 2023. We are fortunate to have Dr. Sharon Lewin, the current President of the IAS, who presided over IAS 2023, speak on this critical area of research so that one day we may hopefully be able to transform HIV from a manageable to a curable disease.


Sharon R. Lewin,AO, FRACP, PhD, FAA, FAHMS

Professor Sharon Lewin is an infectious diseases physician and basic scientist, who is internationally renowned for her research into all aspects of HIV disease and specifically in strategies to achieve an HIV cure. She received her medical degree and PhD from Monash University, Melbourne, Australia and post-doctoral training at Rockefeller University, New York. She is the Director of the Doherty Institute, a joint venture of the University of Melbourne and Royal Melbourne Hospital and Melbourne Laureate Professor of Medicine at the University of Melbourne, Melbourne, Australia. In 2022, she became the inaugural director of the Cumming Global Centre for Pandemic Therapeutics, a new centre at the Doherty Institute established by a philanthropic gift of $250 million from Canadian philanthropist Geoff Cumming and $75 million from the Victorian government. She leads Australia’s national research network on pandemic preparedness, called APPRISE, which includes >100 investigators. She heads a laboratory of 25 scientists and clinicians working on basic and translational research and early phase clinical trials aimed at finding a cure for HIV. In 2019, She was appointed an Officer of the Order of Australia (AO) in recognition of her distinguished service to medical research, and to education and clinical care, in the field of infectious diseases, particularly HIV and AIDS.

Learning Objectives

  • Understand HIV latency and how HIV persists on ART.
  • Know about new assays that can quantify low levels of HIV in people on ART.
  • Be aware of new clinical trials in immunotherapy to achieve an HIV cure.
  • Know about the advances in gene therapy relevant to HIV cure.

Continuing Education Credit Information